Navin Fluorine International Ltd’s stock has delivered almost 60% returns over the last one year. On 10 February, the shares hit an all-time high of ₹6,965 apiece and are now trading around 7% lower.

Navin Fluorine Q3 Results: Navin Fluorine International announced its results for the quarter ending December 2025 (Q3FY26) on February 2. The company posted a strong set of financial numbers, posting ...

Former actor Sameera Reddy may have stepped away from the glamour of Bollywood, but she continues to stay closely connected with her fans through her candid Instagram updates. From motherhood and ...

HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories (REDY.NS), opens new tab hopes to launch a generic version of Novo Nordisk’s (NOVOb.CO), opens new tab blockbuster weight‑loss ...

Shares of Navin Fluorine International slipped on Tuesday after the chemicals major reported earnings for the third quarter of FY26, which more than doubled year on year. At 12:38 pm, Navin Fluorine ...

HYDERABAD, (IANS) – In a setback for Jhansi Reddy, a member of the Congress party, her application for Indian citizenship has been denied by Indian authorities. Jhansi Reddy, who holds American ...

Over two decades after the death of actor Pratyusha, the Supreme Court on Tuesday delivered a verdict, asking the convict - her boyfriend - to surrender. A bench comprising Justices Rajesh Bindal and ...

Feb 18 (Reuters) - India's Stable Money has raised $25 million in a round led by Peak XV Partners, as the fixed-income investment platform aims to triple its assets under management by year-end to 150 ...

Sumathi Reddy is the "Your Health" columnist at The Wall Street Journal, writing about all things health and medicine. Her columns cover everything from exercise and weight-loss drugs to cannabis and ...

Feb 13, 2026, 4:48 PM IST Navin Fluorine Intl. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript Feb 11, 2026, 12:00 AM IST Navin Fluorine Intl. - Announcement under Regulation 30 ...

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...

Citi maintained a sell rating and raised its target price to Rs 5,550 from Rs 4,900. It noted that EBITDA rose 110 per cent year-on-year and margins improved sharply, but said the stock’s recent rally ...